GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Enterprise Value

Albert Labs International (XCNQ:ABRT) Enterprise Value : C$0.75 Mil (As of May. 27, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Albert Labs International's Enterprise Value is C$0.75 Mil. Albert Labs International's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.61 Mil. Therefore, Albert Labs International's EV-to-EBIT ratio for today is 1.24.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Albert Labs International's Enterprise Value is C$0.75 Mil. Albert Labs International's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.63 Mil. Therefore, Albert Labs International's EV-to-EBITDA ratio for today is 1.20.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Albert Labs International's Enterprise Value is C$0.75 Mil. Albert Labs International's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.00 Mil. Therefore, Albert Labs International's EV-to-Revenue ratio for today is .


Albert Labs International Enterprise Value Historical Data

The historical data trend for Albert Labs International's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Enterprise Value Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Enterprise Value
- 2.65

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.62 2.65 3.58 4.09 1.50

Competitive Comparison of Albert Labs International's Enterprise Value

For the Biotechnology subindustry, Albert Labs International's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert Labs International's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Albert Labs International's Enterprise Value falls into.



Albert Labs International Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Albert Labs International's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

Albert Labs International's Enterprise Value for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert Labs International  (XCNQ:ABRT) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Albert Labs International's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.754/0.61
=1.24

Albert Labs International's current Enterprise Value is C$0.75 Mil.
Albert Labs International's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.61 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Albert Labs International's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=0.754/0.627
=1.20

Albert Labs International's current Enterprise Value is C$0.75 Mil.
Albert Labs International's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.63 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Albert Labs International's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.754/0
=

Albert Labs International's current Enterprise Value is C$0.75 Mil.
Albert Labs International's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert Labs International Enterprise Value Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert Labs International (XCNQ:ABRT) Business Description

Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines